Platform Technology Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Platform Technology Partners's PFE Position: Q2 2026 in Review
Platform Technology Partners reduced its Pfizer (PFE) stake by 0.55% in Q2 2026, selling an estimated $3.3K and leaving 22,870 shares worth $551K. The position accounts for 0.09% of the portfolio, ranked #175.
Platform Technology Partners first reported a position in PFE in Q4 2019 and has held it in 25 quarters since. The position peaked at $3.63M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Platform Technology Partners held 22,870 shares of Pfizer worth $551K as of Q2 2026.
- Platform Technology Partners sold 126 Pfizer shares in Q2 2026, an estimated $3.3K.
- Pfizer made up 0.09% of Platform Technology Partners's portfolio in Q2 2026, its #175 holding.
- Platform Technology Partners first reported a position in Pfizer in Q4 2019 and has held it in 25 quarters since.
- Platform Technology Partners's Pfizer position peaked at $3.63M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Platform Technology Partners's 13F filing for Q2 2026, filed 24 Jul 2026.